Ningbo Menovo Pharmaceutical Co., Ltd. (SHA:603538)

China flag China · Delayed Price · Currency is CNY
23.27
+0.69 (3.06%)
Mar 10, 2026, 3:00 PM CST
73.79%
Market Cap 5.13B
Revenue (ttm) 1.54B
Net Income (ttm) 99.48M
Shares Out 220.45M
EPS (ttm) 0.45
PE Ratio 51.38
Forward PE n/a
Dividend 0.05 (0.22%)
Ex-Dividend Date Jun 25, 2025
Volume 12,072,381
Average Volume 6,099,792
Open 22.68
Previous Close 22.58
Day's Range 22.45 - 23.68
52-Week Range 11.40 - 31.15
Beta 0.45
RSI 65.23
Earnings Date Apr 25, 2026

About SHA:603538

Ningbo Menovo Pharmaceutical Co., Ltd. research, develops, produces, and sells pharmaceutical products. The company’s products portfolio includes valsartan, losartan, clopidogrel, perindopril, rosuvastatin calcium, atorvastatin calcium, purin bahrain, and other products. It offers APIs, intermediates, and preparations for the treatment of cardiovascular, central nervous system, gastrointestinal tract, and other therapeutic areas. The company was founded in 2004 and is headquartered in Ningbo, China. [Read more]

Sector Healthcare
Founded 2004
Employees 2,404
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603538
Full Company Profile

Financial Performance

In 2024, SHA:603538's revenue was 1.37 billion, an increase of 12.85% compared to the previous year's 1.22 billion. Earnings were 66.81 million, an increase of 476.64%.

Financial Statements

News

There is no news available yet.